Enteral Feeding Formulas Market

Enteral Feeding Formulas Market Size (2023 to 2028)

The global enteral feeding formulas market size is estimated to grow to USD 8.33 billion by 2028 from USD 5.8 billion in 2023, growing at a CAGR of 7.5% during the forecast period.

Enteral nutrition comprises tube feeding. A unique liquid food mixture containing protein, carbohydrates (sugar), fats, vitamins, and minerals are given through a tube into the stomach or small bowel. A growing number of hospitals and ambulatory care services embrace enteral nutrition as an effective system of clinical nutrition. The enteric feeding formula refers to the nutrition composition sent to the patient's body via the enteral tube. Different conditions require different sets of nutrition based on various factors like the patient's adaptability and unique bodily requirements. Therefore, enteral feeding formulas consisting of vitamins, minerals, proteins, calories, etc., are often prepared according to the patient's need and administered in whichever way is comfortable. However, the wrong administration of enteral nutrition can result in several other problems in the body, which can be dangerous, especially for patients with chronic illnesses. Therefore, the development of the formulas is a crucial step in patient care and needs to be adequately monitored. 

MARKET DRIVERS:

The growing incidence of chronic diseases, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and growing demand for home care primarily boost the global enteral feeding formulas market.

The enteral feeding formula market has been driven by the increased number of patients suffering from cardiovascular disorders, cancer, and diabetes, the leading causes of death. According to the WHO, 17.9 million people died from cardiovascular diseases. Also, as the quality of the food provided by tube feeding has improved, the demand for enteral feeding has seen a significant rise in customers, the senior population has increased, the rate of preterm births has risen, and the need for home care raises factors for market growth. In addition, one of the main reasons is that some people cannot eat their food orally; thus, the need for tube feeding has increased.

The market's core opportunities are improving developing economies' healthcare costs and the rising need for customized medicine. Several companies prioritize product releases, licenses, and other organic development techniques such as trademarks and events. Acquisitions, as well as alliances and agreements, were seen as inorganic growth tactics in the industry. These efforts have opened the way for industry leaders to expand their business and customer base. With the growing demand for enteral feeding formulas in the global premium, market players are expected to benefit from lucrative growth opportunities.

The growing shift toward enteral nutrition supports global enteral feeding formula market expansion.

There is rising adoption of enteral nutrition intake and a gradual shift from parenteral nutrition to enteral nutrition due to the process being more practical and cost-effective. The recent developments in enteral nutrition have led to significant acceptance n the healthcare and ambulatory services settings. In addition, they have helped raise awareness about the system's benefits among the patient population. 

MARKET RESTRAINTS:

Factors such as complications associated with enteral nutrition, patient safety risks, and feeding and medication errors are expected to restrain the growth of the enteral feeding formula market to a certain extent. For example, several different formulations are used for feeding in enteral operations and giving one formula to anyone who isn't a good fit for it can have negative consequences. In addition, certain patients are allergic to specific proteins and fatty acids and must use formulations suitable for their disease. As a result, the market's growth is being hampered by choosing the correct formula. This is the main challenge faced by the market.

Impact of COVID-19 on the global enteral feeding formulas market:

The global spread of the COVID-19 pandemic has caused several serious problems. First, the disruption of supply and demand networks brought on by the epidemic, which resulted in lockdown restrictions, cost businesses a significant amount of money. The healthcare industry was negatively impacted by increased cases and patients and a lack of beds, medical supplies, and staff to care for the patients. Finally, fewer essential surgeries and physicals had to be delayed because the COVID patients were the priority. The new COVID-19 pandemic is projected to affect the global enteral feeding system industry significantly. The SARS-CoV2 virus infects the respiratory tract and is also expected to infect the gastrointestinal tract, neurological systems, and kidneys, impairing nutrient distribution among COVID-19 patients. Gastric enteral feeding is recommended for extreme COVID-19 patients, according to the European Society for Clinical Nutrition and Metabolism recommendations on nutrition in the ICU. It should be started within 48 hours of admission to the ICU, preferably using a pump with a flow regulator. As a result, the COVID-19 pandemic has increased the demand for enteral feeding devices, especially among intensive care units, driving the market.

REPORT COVERAGE:

This research report on the global enteral feeding formulas market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2028.

Enteral Feeding Formulas Market - By Product:

• Polymeric
• Monomeric
• Disease-Specific Formulas

Standard formulas (Polymeric and Monomeric) led the market in the product class, accounting for 54% of the market share in 2022. The availability of a wide range of standard formulas and increased demand for low-cost nutrient formulations account for this high share. The rising use of standard formulas due to their easier availability in the market is another factor for their growth. The formulas also have more credibility and are tested and verified feeding formulas adapted by people, thus justifying their dominance. 

The disease-specific formulas segment is expected to rise faster during the forecast period. Disease-specific formulations are in heavy demand due to the high prevalence of chronic disorders such as cancer, diabetes, and liver failure. In addition, the rising need to develop personalized healthcare systems and the growing advancements in disease-specific formulas are expected to support the market's rise in the segment. 

Enteral Feeding Formulas Market - By Stage:

• Adults
• Pediatrics

Based on the stage, the adult segment accounted for the maximum share of the enteral feeding formula market worldwide in 2022. One of the key factors driving the segment's growth is the increasing use of tube feeds in adults. Furthermore, the commercial availability of a vast range of adult tube feeds or products adds to the segment's large market share. Also, the need for tube feeds among pregnant women is growing. In addition, the market is growing due to the rising demand for tube feeds among patients suffering from neurovascular disorders.

However, the pediatric segment is also expected to show fast growth due to the rising number of cases needing enteral feeding formulas in the cases of children diagnosed with chronic conditions, including in their gastrointestinal tracts. 

Enteral Feeding Formulas Market - By Application:

• Oncology
• Gastroenterology
• Neurology

Based on the application, the oncology application segment held the largest share of the enteral feeding formula market in 2022, primarily due to malnutrition among cancer patients. The rising cancer cases worldwide require an enteral feeding formula to ensure that the patients receive enough nutrition after the taxing procedures of chemotherapies and cancer medication that they have to intake. The body needs to be strong enough to accept the strong medication for cancer, and to ensure this, maintaining health records, diet, and food balance are essential. According to the American cancer society, it is estimated that there could be 609,360 cancer deaths and an estimated 1.9 million new cancer diagnoses in the United States.

Additionally, the gastroenterology segment is expected to show fast growth during the forecast period due to the rising cases of gastrointestinal problems in both adults and children worldwide. 

Enteral Feeding Formulas Market - By End User:

• Hospitals
• LTCS
• Homecare

The long-term care facilities are further divided into home care agencies & hospices, nursing homes, and assisted living facilities based on end-user are expected to dominate the market during the forecast period. The dominance is because enteral feeding is used for nutrition in chronic, life-threatening diseases. Often, the patients are admitted to care facilities or are assigned nurses and caregivers at home for continuous support for everyday life. Such patients also tend to feel more comfortable receiving treatment in a home-based setting or a calm care environment than hospitals, further promoting the segment's growth. 

However, the hospital segment is also expected to grow recently due to rising chronic diseases requiring critical hospital care and 24/7 monitoring, like cancer. Therefore, the advanced infrastructure and development of healthcare settings are expected to help the market flourish. 

Enteral Feeding Formulas Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The North American market is expected to dominate the global enteral feeding formulas market, followed by Europe and Asia-Pacific. Due to the rising burden of chronic diseases such as diabetes, cancer, and other neurological disorders. As a result, it accounted for the highest sales share of 29.7% in 2020. Furthermore, when patients prefer home-based enteral care, visits to hospitals and clinics decrease. Besides that, rising malnutrition is expected to drive up the country's demand for enteral feeding formulas. Due to the growing acceptance of enteral feeding formula for homecare of the senior community, the United States is dominating the market and leading the growth in North America.

Furthermore, the Asia Pacific demand will expand healthily over the forecast period. One of the significant factors driving regional demand is the rising rate of preterm births. India, China, Nigeria, Pakistan, and Indonesia are among the top five countries with the most preterm births, according to the World Health Organization (WHO). In the coming years, the demand will be driven mainly by rising healthcare spending and recent developments in healthcare infrastructure in many countries, including China, Japan, India, and Singapore.

KEY MARKET PARTICIPANTS:

Some of the prominent players in the global enteral feeding formulas market profiled in the report are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).

RECENT MARKET DEVELOPMENTS:

• In September 2022, Novo Holdings, the industry pioneer in introducing plant-based nutrition into healthcare, announced that Kate Farms had completed its Series C fundraising round. The Novo Nordisk Foundation's assets are managed by Novo Holdings, one of the top life science investors in the world.
• In February 2022, Feeding Tube Awareness Week was supported by Nestlé Health Science. Promoting the advantages of feeding tubes as life-saving medical procedures is the goal of Feeding Tube Awareness Week. Even though food is essential to everyone's existence, most people take it for granted. Yet, in 2011, an estimated 16,982 children and approximately 26,600 adults used home tube feeding, according to the BAPEN BANS report1.
• In February 2022, FDA Issues Warning to Consumers Not to Use Specific Powdered Infant Formula Made at Abbott Nutrition's Sturgis, Michigan Facility. The U.S. Food and Drug Administration declared today that it is looking into customer reports of illnesses with Salmonella Newport and Cronobacter sakazakii. According to reports, powdered infant formula made at the Abbott Nutrition factory in Sturgis, Michigan, was ingested in all instances.
• Nestle Health Science offered China's first ready-to-drink protein-based comprehensive nutrition Foods for Special Medical Purposes (FSMPs) for malnourished people in October 2020.
• Victus Inc. debuted one of its revolutionary products, the Abintra Care, in September 2020. It is referred to as specialized nutrition for immune system support.
• Otuska Pharmaceutical Factory Inc. introduced Enoras Liquid, an enteral polymeric enteric nutrition, in June 2020.
• Hormel Foods was named to 3BL Media's 100 Best Corporate Citizens list in June 2020, recognizing exceptional environmental, social, and governance (ESG) transparency and performance among the United States 1,000 biggest publicly listed companies. This boosts the company's credibility and establishes a favorable image in the marketplace.
• Nestle Health Sciences built a global research and development center in Bridgewater, New Jersey, in December 2018. It aided in advancing consumer health care, medical nutrition, and innovative treatments.
• Racol-NF liquid, intended for enteral feeding through tubes and oral administration, was launched by Otsuka Pharmaceutical Factory, Inc. (Japan) in June 2018. The Racol-NF liquid formula is fortified with protein, carbs, minerals, vitamins, lipids, and trace elements, depending on the patient's intake. 
• Authentic Food Blends released a new breakfast meal with eggs, apples, and oats in October 2017. This meal is for persons who are unable to eat orally. Consumers will benefit from the product's launch because it has a robust nutritional profile.